Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture.
Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

PHARMACEUTICALS

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

DOCOSAHEXAENOIC ACID ETHYL ESTER  CRS (150 MG)

DOCOSAHEXAENOIC ACID ETHYL ESTER CRS (150 MG)

84494-72-4

DISCOVER
DOMPERIDONE CRS (120 MG)

DOMPERIDONE CRS (120 MG)

57808-66-9

DISCOVER
DOMPERIDONE MALEATE CRS (150 MG)

DOMPERIDONE MALEATE CRS (150 MG)

83898-65-1

DISCOVER
DOPAMINE HYDROCHLORIDE CRS (20 MG)

DOPAMINE HYDROCHLORIDE CRS (20 MG)

ND

DISCOVER
DOSULEPIN HYDROCHLORIDE CRS (25 MG)

DOSULEPIN HYDROCHLORIDE CRS (25 MG)

ND

DISCOVER
DOSULEPIN IMPURITY A CRS (30 MG)

DOSULEPIN IMPURITY A CRS (30 MG)

ND

DISCOVER
DOXAPRAM HYDROCHLORIDE CRS (50 MG)

DOXAPRAM HYDROCHLORIDE CRS (50 MG)

ND

DISCOVER
DOXORUBICIN HYDROCHLORIDE CRS(150 MG)

DOXORUBICIN HYDROCHLORIDE CRS(150 MG)

25316-40-9

DISCOVER
Damascone cis-beta

Damascone cis-beta

25316-40-9

DISCOVER
DOXYCYCLINE HYCLATE CRS (50 MG)

DOXYCYCLINE HYCLATE CRS (50 MG)

24390-14-5

DISCOVER
Diminazene aceturate

Diminazene aceturate

908-54-3

DISCOVER
Diclofenac methyl ester

Diclofenac methyl ester

15307-78-5

DISCOVER